Document:

EX-10.2

 Exhibit 10.2 

STOCKHOLDER CONVERSION AGREEMENT 

THIS STOCKHOLDER CONVERSION AGREEMENT (this “Agreement”), dated as of March 17, 2022 is by and among Coca-Cola
Consolidated, Inc., a Delaware corporation (the “Company”), and the Persons listed on the Schedule of Holders attached hereto (each a “Holder” and collectively, the “Holders”). 

WHEREAS, the Holders currently own an aggregate of 1,227,546 shares (the “Class B Shares”) of the
Company’s Class B Common Stock, par value of $1.00 per share (“Class B Common Stock”); and 

WHEREAS, J. Frank Harrison, III (“JFHIII”) has sole voting and investment power over the Class B Shares pursuant to the
terms and conditions of the applicable trust documents or other agreements (collectively, the “Applicable Voting and Investment Power Documents”); 

WHEREAS, the Holders, JFHIII and the others party thereto have entered into a Simplification Plan and Agreement in which the Holders and
JFHIII have agreed, subject to the execution and delivery of this Agreement and to the fulfillment of certain other terms and conditions, to modify the Applicable Voting and Investment Power Documents and to take such other actions as may be
necessary to terminate JFHIII’s sole voting and investment power over the Class B Shares effective from and after the conversion of the Class B Shares into Common Shares (as defined below); 

WHEREAS, concurrently herewith, Harrison Limited Partnership One, a North Carolina limited partnership in which certain of the Holders hold a
direct and indirect interest (“HLP”), and the Company have entered into a Purchase and Sale Agreement (the “Purchase and Sale Agreement”) whereby HLP has agreed to sell to the Company those certain real estate
parcels and improvements commonly known as the Snyder Production Center that HLP currently leases to the Company; 
 WHEREAS, the
Class B Shares shall be converted into fully paid and nonassessable shares of the Company’s Common Stock, par value of $1.00 per share (“Common Stock”), upon the terms and conditions set forth herein on a one share for one
share basis (the Class B Shares so converted to Common Stock, the “Common Shares”); and 
 WHEREAS, the Holders and
the Company desire to enter into this Agreement to provide for the details and process for the conversion of the Class B Shares into the Common Shares and the registration of the Common Shares for resale pursuant to the Company’s existing
automatic shelf registration statement on Form S-3ASR, filed with the Securities and Exchange Commission (the “SEC”) on December 15, 2020 (File
No. 333-251358) (the “Automatic Shelf Registration Statement”) and to set forth the restrictions pursuant to which the Holders are permitted to transfer the Common Shares. 

NOW, THEREFORE, in consideration of the mutual covenants contained herein and other good and valuable consideration, the receipt and
sufficiency of which are hereby acknowledged, the parties to this Agreement hereby agree as follows: 

 1. Definitions. As used herein, the following terms will have
the following meanings: 
 “Agreement” has the meaning set forth in the Preamble. 

“Applicable Voting and Investment Power Documents” has the meaning set forth in the Preamble. 

“AST” means American Stock Transfer & Trust Company, LLC, the Transfer Agent and Registrar for the Common Stock.

 “Automatic Shelf Registration Statement” has the meaning set forth in the Preamble. 

“Blackout Period” has the meaning set forth in Section 5(a). 

“Business Day” means any day that is not a Saturday, a Sunday or other day on which Nasdaq is closed for trading. 

“Class B Common Stock” has the meaning set forth in the Preamble. 

“Class B Shares” has the meaning set forth in the Preamble. 

“Common Shares” has the meaning set forth in the Preamble. 

“Common Stock” has the meaning set forth in the Preamble. 

“Company” has the meaning set forth in the Preamble. 

“Effective Period” has the meaning set forth in Section 4(b). 

“Exchange Act” means the Securities Exchange Act of 1934, as amended, and all rules and regulations promulgated thereunder,
as each may be amended from time to time. 
 “FINRA” means the Financial Industry Regulatory Authority. 

“HLP” has the meaning set forth in the Preamble. 

“Holders” has the meaning set forth in the Preamble. 

“JFHIII” has the meaning set forth in the Preamble. 

“Nasdaq” means The NASDAQ Global Select Market, the exchange on which the shares of Common Stock are listed. 

“Person” means any natural person, partnership, firm, corporation, limited liability company, association, cooperative, joint
stock company, trust, joint venture or government entity, or any department, agency or political subdivision thereof, or any other entity, including any unincorporated organization, syndicate or affiliated group. 

“Prospectus Supplement” means the resale prospectus supplement to the Company’s Automatic Shelf Registration Statement
covering the Common Shares. 

  
 2 

 “Sale Transaction” has the meaning set forth in Section 5(a). 

“SEC” means the U.S. Securities and Exchange Commission, or any successor thereto. 

“Securities Act” means the Securities Act of 1933, as amended, and all rules and regulations promulgated thereunder, as each
may be amended from time to time. 
 2. Class B Shares Conversion Process. 

(a) In accordance with Fourth(b)(3) of the Company’s Restated Certificate of Incorporation, as of the closing date of the Purchase and
Sale Agreement, each of the Holders shall furnish the Company with a written notice of the irrevocable request for conversion of their shares of Class B Common Stock into shares of Common Stock in the form attached hereto as Exhibit A
(the “Conversion Notice”), which Conversion Notice will (i) be addressed to each of the Company’s principal office and AST, (ii) list the name and address of the Holder and state the number of shares of Class B
Common Stock to be converted into shares of Common Stock, (iii) be accompanied by a certificate or certificates, properly endorsed and ready for transfer, (iv) provide instructions to AST to cancel the applicable shares of Class B
Common Stock and issue shares of Common Stock in exchange therefore, (v) request that such conversion be completed as promptly as possible following receipt of such notice, (vi) request AST to deposit the shares of Common Stock issued in
exchange for the converted Class B Common Stock in book-entry form with the same restrictive legend currently on such certificated shares of Class B Common Stock and (vii) provide an acknowledgement by such Holder that the conversion
is effective upon delivery to the Company of the Conversion Notice along with the certificate or certificates, properly endorsed and ready for transfer. 

(b) As soon as practicable (and no later than 10 days after the execution of this Agreement), complete and submit the documentation required by
AST to complete the conversion of the Class B Shares into Common Shares, including, but not limited to (i) an instruction notice to AST to convert such Class B Shares into Common Shares that includes the information set forth in the
Conversion Notice, (ii) delivery of share certificates representing the shares of Class B Common Stock owned by such Holder, (iii) completion and delivery of AST’s Form “Transfer of Ownership with W-9” to AST and the Company, (iv) a Medallion Signature Guarantee to guarantee the legal capacity of each Holder to execute the “Transfer of Ownership with W9” form OR a Waiver of Medallion
Signature Guarantee, and (v) such other information necessary for AST to create the book-entry account for each of the Holders. 
 (c)
Following receipt by the Company and AST of all of the documents necessary for the conversion of the Class B Shares into Common Shares as set forth in Section 2(a), the Company and the Holders will provide AST such information as
reasonably requested to allow AST to take such actions to deposit such applicable shares of Common Stock to be issued in exchange for such Class B Common Stock in book-entry form with the same restrictive legend currently on such certificated
shares of Class B Common Stock and otherwise complete the conversion process. 

  
 3 

 (d) Promptly following the conversion of the Class B Shares into Common Shares, and in
accordance with the Exchange Act, the Holders will file with the SEC an amendment to the Schedule 13D/A filed on October 26, 2021, or a Schedule 13G, as applicable, to disclose the conversion of the Class B Shares and their beneficial
ownership of the Common Shares.  
 3. Resale Prospectus Supplement. 

(a) Promptly following the date hereof and in connection with the conversion of the Class B Shares to Common Shares pursuant to
Section 2, the Holders will deliver to the Company a completed selling Stockholder questionnaire in the form of Exhibit B. 
 (b)
Following receipt by the Company of a completed selling Stockholder questionnaire by each of the Holders, the Company will use its commercially reasonable efforts to promptly file the Prospectus Supplement with the SEC. The Prospectus Supplement
will include the plan of distribution attached hereto as Exhibit C. The Holders agree to use their reasonable efforts to cooperate with the Company with respect to the preparation of the Prospectus Supplement. 

(c) Notwithstanding the foregoing, if the Company determines in good faith and in its sole discretion that it would be materially detrimental
to the Company and its stockholders for such Prospectus Supplement to be used for the sales of the Common Shares because such action would (i) materially interfere with a significant acquisition, disposition, corporate reorganization, or other
similar transaction involving the Company; (ii) require premature disclosure of material information that the Company has a bona fide business purpose for preserving as confidential; (iii) occur during the marketing period of an
underwritten financing or similar engagement with an investment bank or a non-deal roadshow; or (iv) render the Company unable to comply with requirements under the Securities Act or Exchange Act, then
the Company will have the right to defer taking action with respect to the filing of the Prospectus Supplement for a period of not more than sixty (60) days. 

4. Registration Procedures. The Company will, as promptly as reasonably possible following the filing with the SEC
of the Prospectus Supplement: 
 (a) deliver to AST a notice that the Prospectus Supplement has been filed with the SEC and is effective;

 (b) use its commercially reasonable efforts to prepare and file with the Commission such amendments, post-effective amendments and
supplements to such Automatic Registration Statement and the Prospectus Supplement used in connection therewith as may be necessary to keep such Automatic Registration Statement effective for resales of the Common Shares for a period ending the
earlier of (i) three years from the date of the initial filing with the SEC of the Automatic Shelf Registration Statement or (ii) until the plan of distribution of the Common Shares as contemplated in the Prospectus Supplement has been
completed (the “Effective Period”); 
 (c) furnish to the Holders such numbers of copies of the Prospectus Supplement as
required by the Securities Act, along with such other documents as the Holders may reasonably request in order to facilitate resales of their Common Shares; 

  
 4 

 (d) notify the Holders (i) promptly after it receives notice thereof, of the date and
time when any Prospectus Supplement to the Automatic Shelf Registration Statement has been filed, (ii) promptly after receipt thereof, of any request by the SEC or any state securities authority for the amendment or supplementing of such
Automatic Shelf Registration Statement or Prospectus Supplement or for additional information, (iii) promptly after it receives notice thereof, of the issuance by the SEC or any state securities regulator of any stop order suspending such
Automatic Shelf Registration Statement or the initiation of any proceedings for that purpose, (iv) promptly after receipt thereof, of any notification with respect to the suspension of qualification of the Common Shares for sale in any
jurisdiction or the initiation of any proceeding for such purpose, and (v) promptly during any time when an Automatic Shelf Registration Statement or Prospectus Supplement relating thereto is required to be delivered under the Securities Act,
any event has occurred, the result of which is that the Prospectus Supplement included in such Automatic Shelf Registration Statement or any other prospectus as then in effect contains an untrue statement of a material fact or omits any material
fact necessary to make the statements therein, in the light of the circumstances in which they were made, not misleading, and, at the request of Holders of a majority of the then outstanding Common Shares included in such Automatic Shelf
Registration Statement, the Company will promptly prepare and file a supplement or amendment to such Prospectus Supplement so that, as thereafter delivered to the purchasers of such Common Shares pursuant to the Prospectus Supplement, such
Prospectus Supplement will not contain an untrue statement of a material fact or omit to state any material fact necessary to make the statements therein not misleading in the light of the circumstances under which they were made; 

(e) prepare and file promptly with the SEC, and notify the Holders of the then outstanding Common Shares included in such Prospectus Supplement
prior to the filing of, such amendments or supplements to such Automatic Shelf Registration Statement or Prospectus Supplement as may be necessary to correct any statements or omissions if, at the time when a Prospectus Supplement relating to such
Common Shares is required to be delivered under the Securities Act, any event has occurred the result of which any such Prospectus Supplement or any other prospectus as then in effect would include an untrue statement of a material fact or omit to
state any material fact necessary to make the statements therein not misleading in the light of the circumstances under which they were made not misleading; 

(f) use its commercially reasonable efforts to cause all such Common Shares to be listed on the Nasdaq; 

(g) use its commercially reasonable efforts to prevent the issuance of any stop order suspending the effectiveness of the Automatic Shelf
Registration Statement, or of any order suspending or preventing the use the Prospectus Supplement or suspending the qualification of any Common Shares for sale in any jurisdiction, and in the event of the issuance of any such stop order or other
such order the Company will advise the holders of the then outstanding Common Shares included in such Prospectus Supplement of such stop order or other such order promptly after it will receive notice or obtain knowledge thereof and will use its
reasonable best efforts to promptly obtain the withdrawal of such order; 
 (h) use commercially reasonable efforts to cooperate with any
Holder in connection with any filings required to be made with FINRA by such Holder; 

  
 5 

 (i) use its commercially reasonable efforts to register or qualify such Common Shares under
such other securities or blue sky laws of such jurisdictions as any Holder reasonably requests (provided that the Company will not be required to (x) qualify generally to do business in any jurisdiction where it would not otherwise be
required to qualify but for this subparagraph, (y) consent to general service of process in any such jurisdiction, or (z) subject it to taxation in any such jurisdiction); 

(j) provide and cause to be maintained a transfer agent and registrar for all Common Shares; and 

(k) take such other actions and deliver such other documents and instruments as may be reasonably necessary to facilitate the registration and
disposition of the Common Shares in the jurisdictions in which such Common Shares have been registered and qualified for disposition as contemplated hereby. 

5. Holder Covenants. Each Holder covenants and agrees as follows: 

(a) Blackout Periods. Each Holder of Common Shares agrees that it will not sell, transfer, make any short sale of, grant any option for
the purchase of or enter into any hedging or similar transaction with the same economic effect as a sale (including sales pursuant to Rule 144 promulgated under the Securities Act) (a “Sale Transaction”) of its Common Shares
(i) during the period that is ten (10) Trading Days prior to the end of the Company’s fiscal quarter and through the date that is three (3) Trading Days after the earnings release is filed for such fiscal quarter,
(ii) during any period set forth in the Company’s written insider trading compliance program, to the extent applicable, or (iii) upon written notice from the Company made in good faith to suspend any Sale Transactions until such time
as the Company provides written notification of the lifting of such suspension (each, a “Blackout Period”). The Company may impose stop transfer instructions with respect to the Common Shares subject to the foregoing restriction
until the end of such period. 
 (b) Trade Volume Limitations. Each Holder agrees that it will not undertake any Sale Transaction that
would result in an excess of its respective Pro Rata Portion (as set forth on the attached Schedule of Holders) of Common Shares being sold in any three (3) consecutive month period. 

(c) Notice to AST. Following the filing of the Prospectus Supplement and as long as the related Automatic Shelf Registration Statement
remains valid and outstanding, at each such time that a Holder determines it has a present intention to sell Common Shares in a Sale Transaction over the following 60 days, the Holder will send a written notice to AST (with a copy to the Company) to
that effect and specifying the number of Common Shares it intends to sell. Upon receipt of such notice, the Company will instruct AST to remove the restrictive legends from the Common Shares subject to such present intention to sell. 

  
 6 

 (d) Indemnification. 

(i) In connection with the Prospectus Supplement, each Holder will furnish to the Company in writing such information as the
Company reasonably requests in writing for use in connection with such Prospectus Supplement and each Holder, to the extent permitted by applicable law, will, severally and not jointly, (i) indemnify the Company, its directors and officers and
each Person who controls the Company (within the meaning of the Securities Act) against, and pay and reimburse the foregoing Persons for, any losses, claims, damages, liabilities and expenses resulting from any untrue or alleged untrue statement of
material fact contained or incorporated by reference in the Registration Statement or Prospectus Supplement, or any amendment thereof or supplement thereto, used by the Company or the Holders, or any omission or alleged omission of a material fact
required to be stated therein or necessary to make the statements therein (and with respect to the Prospectus Supplement, in the light of the circumstances under which they were made) not misleading, and (ii) reimburse the Company, its
directors and officers and each Person who controls the Company (within the meaning of the Securities Act) for any legal or other expenses reasonably incurred by such Persons in connection with the investigation or defense of such loss, claim,
damage, liability or expense, but in the case of the foregoing clause (i) and clause (ii), (x) solely in connection with any registration, offer or sale of the Common Shares and (y) only to the extent the untrue statement or alleged untrue
statement or omission or alleged omission was made in such Registration Statement or Prospectus Supplement, or any amendment thereof or supplement thereto, in reliance upon and in conformity with written information furnished by such Holder to the
Company expressly for use therein. No Holder will be liable in respect of indemnity amounts for more than the net proceeds actually received by such Holder in connection with the sale of such Common Shares. 

(ii) Any Person entitled to indemnification hereunder will (A) give prompt written notice to the indemnifying party of any
claim with respect to which it seeks indemnification; provided that failure to give such notice will not affect the right of such Person to indemnification hereunder unless such failure is materially prejudicial to the indemnifying
party’s ability to defend such claim, and (B) permit such indemnifying party to assume the defense of such claim with counsel reasonably satisfactory to the indemnified party unless either (Y) in such indemnified party’s
reasonable judgment a conflict of interest between such indemnified and indemnifying parties may exist with respect to such claim or (Z) there are one or more legal defenses available to such indemnified party that are substantially different
from or additional to those available to the indemnifying party. If such defense is assumed, the indemnifying party will not be subject to any liability for any settlement made by the indemnified party without its prior written consent, which will
not be unreasonably withheld, conditioned or delayed. An indemnifying party who is not entitled to, or elects not to, assume the defense of a claim will not be obligated to pay the fees and expenses of more than one counsel (plus any local counsel
necessary for defending such claim as reasonably determined by an indemnified party), if any, for all parties indemnified by such indemnifying party with respect to such claim, unless in the reasonable judgment of any indemnified party a conflict of
interest may exist between such indemnified party and any other of such indemnified parties with respect to such claim. 

(iii) No indemnifying party will, except with the consent of the indemnified party, consent to the entry of any judgment or
enter into any settlement that does not include as an unconditional term thereof the giving by the claimant or plaintiff to such indemnified party of a release from all liability in respect to such claim or litigation in form and substance
reasonably satisfactory to such indemnified party. 

  
 7 

 (e) These indemnification provisions will survive the transfer of Common Shares and the
termination of this Agreement. 
 (f) Each Holder hereby irrevocably appoints JFHIII as his, her or its true and lawful attorney-in-fact, with the power to appoint his substitute, and hereby authorize(s) JFHIII to represent and to vote, all of the shares of Common Stock and Class B Common
Stock of the Company that each such Holder is entitled to vote at the 2022 Annual Meeting of Stockholders of the Company to be held at 9:00 a.m., Eastern Time, on Tuesday, May 10, 2022 via live audio webcast, and any adjournment or postponement
thereof. The proxy holder is further authorized to vote on such other business as may properly come before the meeting or any adjournment or postponement thereof. 

6. Miscellaneous. 

(a) Costs and Expenses. Except as set forth herein, each of the parties hereto agrees to pay the expenses incurred by it in connection
with the negotiation, preparation, execution and delivery of this Agreement, the filing of the Prospectus Supplement with the SEC, including any fees and expenses related thereto, and the consummation of the transactions contemplated hereby,
including the fees and expenses of counsel to such party. 
 (b) Governing Law; Severability; Waiver of Jury Trial. 

(i) This Agreement, together with any claim or defense arising out of or based upon this Agreement or relating to the subject
matter hereof, will in all respects be governed by, interpreted, and construed in accordance with, and all rights and remedies hereunder will be governed by, the laws of the State of Delaware (without regard to any conflict of law provisions that
would result in the application of the laws of another jurisdiction). If it is determined by a court of competent jurisdiction that any provision of this Agreement is invalid under applicable law, such provision will be ineffective only in such
jurisdiction and only to the extent of such prohibition or invalidity, without invalidating the remainder of this Agreement. 

(ii) TO THE EXTENT NOT PROHIBITED BY APPLICABLE LAW THAT CANNOT BE WAIVED, EACH PARTY HERETO WAIVES, AND COVENANTS THAT SUCH
PARTY WILL NOT ASSERT (WHETHER AS PLAINTIFF, DEFENDANT OR OTHERWISE), ANY RIGHT TO TRIAL BY JURY IN ANY FORUM IN RESPECT OF ANY ISSUE, CLAIM OR PROCEEDING ARISING OUT OF THIS AGREEMENT OR RELATING TO THE SUBJECT MATTER HEREOF OR IN ANY WAY CONNECTED
WITH THE DEALINGS OF ANY OTHER PARTY HERETO IN CONNECTION WITH ANY OF THE ABOVE, IN EACH CASE, WHETHER NOW EXISTING OR HEREAFTER ARISING AND WHETHER IN CONTRACT, TORT OR OTHERWISE. 

Each party hereto may file an original counterpart or a copy of this Section 6(b)(i) with any court as written evidence of
the consent of parties hereto to the waiver of their rights to trial by jury. 

  
 8 

 (c) Amendment and Waiver. This Agreement may be amended, modified or waived only upon
the written approval of the Company and by the Holders of at least a majority in interest of the Common Shares at the time in question. The waiver by any party of a breach of any provision of this Agreement will not operate or be construed as a
further or continuing waiver of such breach or as a waiver of any other or subsequent breach. No failure on the part of any party to exercise, and no delay in exercising, any right, power or remedy hereunder will operate as a waiver thereof, nor
will any single or partial exercise of such right, power or remedy by such party preclude any other or further exercise thereof or the exercise of any other right, power or remedy. No course of dealing between or among the parties hereto will be
deemed effective to modify, amend or discharge any part of this Agreement or any rights or obligations of any such party or such holder under or by reason of this Agreement. 

(d) Changes in Company Securities. If, and as often as, there are any changes in the Common Stock by way of stock split, stock dividend,
combination or reclassification, or through merger, consolidation, reorganization or recapitalization, or by any other means, and only to the extent Common Shares are held by the Holders, appropriate adjustment will be made in the provisions hereof
as may be required so that the rights and privileges granted hereby will continue with respect to the Common Shares as so changed and the Company will make appropriate provision in connection with any merger, consolidation, reorganization or
recapitalization that any successor to the Company (or resulting parent thereof) will agree, as a condition to the consummation of any such transaction, to expressly assume the Company’s obligations hereunder. 

(e) Notices. All notices and other communications given or made pursuant to this Agreement will be in writing and will be deemed
effectively given upon the earlier of actual receipt or: (i) personal delivery to the party to be notified; (ii) when sent, if sent by electronic mail or facsimile during the recipient’s normal business hours, and if not sent during
normal business hours, then on the recipient’s next business day; (iii) five (5) days after having been sent by registered or certified mail, return receipt requested, postage prepaid; or (iv) one (1) business day after the business
day of deposit with a nationally recognized overnight courier, freight prepaid, specifying next-day delivery, with written verification of receipt. All communications will be sent to the respective parties at
their addresses as set forth on the Schedule of Holders hereto, or to the principal office of the Company and to the attention of its General Counsel, in the case of the Company, or to such email address, facsimile number, or address as subsequently
modified by written notice given in accordance with this Section. 
 (f) Complete Agreement; Counterparts. This Agreement constitutes
the entire agreement among the Company and the Holders and supersedes all other agreements and understandings, both written and oral, among the parties or any of them, with respect to the subject matter hereof. Other than as expressly contained
herein, the parties hereto have made no other representations and warranties to each other. This Agreement may be executed by any one or more of the parties hereto in any number of counterparts, each of which will be deemed to be an original, but
all such counterparts will together constitute one and the same instrument. Counterparts may be delivered via facsimile, electronic mail (including any electronic signature covered by the U.S. federal ESIGN Act of 2000, Uniform Electronic
Transactions Act, the Electronic Signatures and Records Act or other applicable law, e.g., www.docusign.com) or other transmission method and any counterpart so delivered will be deemed to have been duly and validly delivered and be valid and
effective for all purposes. 

  
 9 

 (g) Descriptive Headings, etc. In this Agreement, unless otherwise specified or where
the context otherwise requires: 
 (i) the headings in this Agreement are inserted for convenience only and will not be
construed as a part of this Agreement or serve as a limitation or expansion on the scope of any term or provision of this Agreement; 

(ii) words importing any gender will include other genders; 

(iii) words importing the singular only will include the plural and vice versa; 

(iv) the words “include”, “includes” or “including” will be deemed to be followed by the words
“without limitation”; 
 (v) the words “hereof,” “herein” and “herewith” and words of
similar import will, unless otherwise stated, be construed to refer to this Agreement as a whole and not to any particular provision of this Agreement; 

(vi) references to “Exhibits,” “Sections” or “Schedules” will be to Exhibits, Sections or
Schedules of or to this Agreement; 
 (vii) references to any Person include the successors and permitted assigns of such
Person; 
 (viii) the use of the words “or,” “either” and “any” will not be exclusive; 

(ix) references to any agreement, contract or schedule, unless otherwise stated, are to such agreement, contract or schedule as
amended, modified or supplemented from time to time in accordance with the terms hereof and thereof; and 
 (x) the parties
hereto have participated jointly in the negotiation and drafting of this Agreement; accordingly, in the event an ambiguity or question of intent or interpretation arises, this Agreement will be construed as if drafted jointly by the parties hereto,
and no presumption or burden of proof will arise favoring or disfavoring any party hereto by virtue of the authorship of any provisions of this Agreement. 

(h) Remedies. Each Holder will have all rights and remedies set forth in this Agreement and all rights and remedies that such Person has
been granted at any time under any other agreement or contract and all of the rights that such Person has under any applicable law. Any Person having any rights under any provision of this Agreement or any other agreements contemplated hereby will
be entitled to enforce such rights specifically (without posting a bond or other security) to recover damages by reason of any breach of any provision of this Agreement and to exercise all other rights granted by applicable law. All remedies
hereunder are cumulative and are not exclusive of any other remedies provided by law. 
 (i) Successors and Assigns. Except as
otherwise provided herein, this Agreement will bind and inure to the benefit of and be enforceable by the Company and the Holders and each of their respective successors in interest. 

*    *    *    *    * 

  
 10 

 IN WITNESS WHEREOF, the parties hereto have executed this Stockholder Conversion
Agreement as of the date first above written. 
  

					
	COMPANY:
	
	COCA-COLA CONSOLIDATED, INC.
		
	By:	 	 /s/ F. Scott Anthony

		 	Name:	 	F. Scott Anthony
		 	Title:	 	Executive Vice President &
		 		 	Chief Financial Officer
	
	HOLDERS:
	
	JFH FAMILY LIMITED PARTNERSHIP—SW1
		
	By:	 	J. Frank Harrison Family, LLC
	Its:	 	General Partner
		
	By:	 	 /s/ J. Frank Harrison, III

		 	Name:	 	J. Frank Harrison, III
		 	Title:	 	Chief Manager and Consolidated Stock Manager
	
	ANNE LUPTON CARTER TRUST f/b/o SUE ANNE H. WELLS
		
	By:	 	 /s/ J. Frank Harrison, III

		 	Name:	 	J. Frank Harrison, III
		 	Title:	 	Trustee and Authorized Signatory as Holder of
		 		 	Personal Powers re: Coca-Cola Consolidated, Inc. Stock

  

					
	JFH FAMILY LIMITED PARTNERSHIP—DH1
		
	By:	 	J. Frank Harrison Family, LLC
	Its:	 	General Partner
		
	By:	 	 /s/ J. Frank Harrison, III

		 	Name:	 	J. Frank Harrison, III
		 	Title:	 	Chief Manager and Consolidated Stock Manager
	
	ANNE LUPTON CARTER TRUST f/b/o DEBORAH S. HARRISON
		
	By:	 	 /s/ J. Frank Harrison, III

		 	Name:	 	J. Frank Harrison, III
		 	Title:	 	Trustee and Authorized Signatory as Holder of
		 		 	Personal Powers re: Coca-Cola Consolidated, Inc. Stock

  

  
 [Signature Page to
Stockholder Conversion Agreement] 

 SCHEDULE OF HOLDERS 

 

									
	 Holder and Address
	  	Number of Class B
Shares Owned	 	  	Pro Rata Portion	 
	 JFH Family Limited Partnership—SW1

c/o David Smith, LBMC,

605 Chestnut Street, Suite 1100,

Chattanooga, Tennessee 37450
	  	 	535,178	 	  	 	76,295	 
	 Anne Lupton Carter Trust f/b/o Sue Anne H. Wells

c/o David Smith, LBMC,

605 Chestnut Street, Suite 1100,

Chattanooga, Tennessee 37450
	  	 	78,595	 	  	 	11,205	 
	 JFH Family Limited Partnership—DH1

c/o David Smith, LBMC,

605 Chestnut Street, Suite 1100,

Chattanooga, Tennessee 37450
	  	 	535,178	 	  	 	76,295	 
	 Anne Lupton Carter Trust f/b/o Deborah S. Harrison

c/o David Smith, LBMC,

605 Chestnut Street, Suite 1100,

Chattanooga, Tennessee 37450
	  	 	78,595	 	  	 	11,205	 
		  	  
	  
	 	  	  
	  
	 
	 Total
	  	 	1,227,546	 	  	 	175,000	 
		  	  
	  
	 	  	  
	  
	 

  
 S-1 

 EXHIBIT A 

NOTICE OF ELECTION TO CONVERT 

CLASS B COMMON STOCK 
  

	To:	 Coca-Cola Consolidated, Inc. 

4100 Coca-Cola Plaza 
 Charlotte,
NC 28211 
 Attention: Beau Fisher, Esq. (beau.fisher@cokeconsolidated.com) 

The undersigned, [NAME OF HOLDER OF RECORD] (“Holder”), owner of the enclosed stock certificate(s) No(s). _____, representing an
aggregate of ______ shares (the “Class B Shares”) of Class B Common Stock, $1.00 par value (the “Class B Common Stock”), of Coca-Cola Consolidated, Inc. (the
“Issuer”), hereby irrevocably exercises on behalf of Holder and Holder’s heirs, executors, representatives, estate, successors and assigns, the right and option to convert the enclosed Class B Common Stock into shares of Common
Stock, $1.00 par value (the “Common Stock”, and the Class B Shares so converted to Common Stock the “Common Shares”), of the Issuer, as promptly as possible following receipt of this notice and in accordance
with the terms of the Stockholder Conversion Agreement, and directs that the Common Shares of the Issuer issuable and deliverable upon such conversion be issued in book-entry form with the same restrictive legend currently on such converted
Class B Common Shares in the name of the Holder (or such other name as shall be designated below) at the address designated below. If shares are to be registered in the name of a person other than the Holder, the Holder will pay any transfer
taxes payable with respect thereto. Holder hereby expressly acknowledges that the conversion of the Class B Shares to Common Shares shall be deemed effective upon delivery to the Issuer of this Conversion Notice along with the certificate or
certificates, properly endorsed and ready for transfer. 
  

							
	Dated:	 	  
	  		  	  

		 	                                     
                                         
              	  		  	Name:
			
	Signature Guaranteed By:	  		  	
			
	  
	  		  	
	
	Number of shares of Class B Common Stock to be Converted:
                                         
                           
			
	  
	  		  	  

	(Name in which Common Shares are to be issued)	  		  	(Address)
			
	  
	  		  	  

	(City and State)	  		  	(Tax Identification Number)

  
 A-1 

 EXHIBIT B 

SELLING STOCKHOLDER 

QUESTIONNAIRE RELATING TO 

REGISTRATION OF 

COCA-COLA CONSOLIDATED, INC. COMMON STOCK 

ON REGISTRATION STATEMENT ON FORM S-3 

 

	TO:	     [SELLING STOCKHOLDER NAME] 

 

	FROM:	   Coca-Cola Consolidated, Inc. 

 

	DATE:	     [•], 2022 

This questionnaire (this “Questionnaire”) is being distributed in connection with the anticipated filing by Coca-Cola
Consolidated, Inc. (the “Corporation”) with the Securities and Exchange Commission of a registration statement on Form S-3 (the “Registration Statement”), pursuant to which
the Corporation intends to provide for the resale of certain shares (the “Shares”) of the Corporation’s common stock held by you as a Selling Stockholder. 

The furnishing of accurate and complete responses to the questions posed in this Questionnaire is an extremely important part of the
registration process. The inclusion of inaccurate or incomplete disclosures in the Registration Statement can result in potential liabilities, both civil and criminal, to the Corporation and to the individuals who furnish the information.
Accordingly, you are advised to consult your own securities counsel regarding the consequences of being named as a Selling Stockholder, as well as the meaning or implication of any of the terminology used in this Questionnaire or as to the
significance of any particular fact situation. 
 Please complete, sign, and return one copy of this Questionnaire by facsimile, email
or overnight courier as soon as possible. 
 Coca-Cola Consolidated, Inc. 

4100 Coca-Cola Plaza 

Charlotte, NC 28211 

Attention:    Beau Fisher, Esq. 

Email:         beau.fisher@cokeconsolidated.com 

The Corporation must receive a signed and fully completed questionnaire from the you in order to include your Shares in the Registration
Statement. Please remember to make a copy of the completed Questionnaire for your files. 
 Please review Annex A for a list
of defined terms, which are in bold/italics in this Questionnaire.  
 Please give a response to every question,
indicating “None” or “Not Applicable” where appropriate. Each question should be answered based on information available to you as of the date you complete this Questionnaire. Please also promptly inform the
Corporation if there is any change or inaccuracies in the information supplied in answer to this Questionnaire. 

  
 B-1 

	A.	 GENERAL INFORMATION 

 

	1.	 Please provide the following information about the Selling Stockholder: 

Full legal name of record holder:
                                         
                    
 Address of record
holder:
                                         
                                

Identity of beneficial owner (if different than record holder):
                  
 Name of contact person:
                                         
                                  

Telephone number of contact person:
                                         
              

Email address of contact person:
                                         
                     
  

	2.	 Since January 1, 2019, have any of your Affiliates been an officer, director or employee of
the Corporation or any of its subsidiaries or Affiliates? If you mark “Yes,” please provide detailed information regarding such relationship on a separate piece of paper. 

Yes ☐                    No ☐

  

	3.	 Except as set forth in A.2., since January 1, 2018, have you had any other direct or indirect material
relationship with the Corporation or any of its subsidiaries or affiliates? For purposes of this Item, please include information with respect to any other material relationship with the Corporation that any of your “immediate family
members” may have had during the relevant period. 

 Yes
☐                    No ☐ 
  

	4.	 Are you a registered broker-dealer or an Affiliate of a registered broker-dealer? If so, identify
the registered broker-dealer and describe the nature of the affiliation(s) on a separate piece of paper: 

 Yes
☐                    No ☐ 
  

	B.	 SECURITY HOLDINGS 

You must include shares Beneficially Owned as of the date you complete this Questionnaire. 

 

	1.	 List below any shares of the Corporation’s securities Beneficially Owned by the Selling
Stockholder: 

  

					
	Class of Security	  	Number of Shares	  	Record Holder of such Shares
			
	                            	  	                                   
     	  	                                   
             

  

	2.	 Do you claim not to have (“disclaim”) Beneficial Ownership under the securities laws of
any of these securities? 

 Yes
☐                     No ☐ 

If you disclaim Beneficial Ownership, please explain why on a separate piece of paper. 

  
 B-2 

	3.	 If there are other securities of the Corporation held in the name of another person (for example, a
trust or LLC) that the Selling Stockholder has the power to vote or sell or otherwise Beneficially Own, please also list below: 

  

							
		  	Class of Security	  	Number of Shares	  	Record Holder of such Shares
		
		  	  

  

	4.	 Is there any pledge, lien or charge of any kind against any of the Corporation’s securities
Beneficially Owned by you? If “Yes,” please provide detailed information regarding such pledge, lien or charge on a separate piece of paper. 

Yes ☐                    No ☐

  

	5.	 Is there any unresolved dispute regarding the Selling Stockholder’s ownership of the Corporation’s
securities? 

 Yes
☐                    No ☐ 
  

	6.	 Is the Selling Stockholder the subject of a bankruptcy or insolvency proceeding, receivership, liquidation,
reorganization, or other judicial proceeding? 

 Yes
☐                    No ☐ 
  

	7.	 With respect to any of the Corporation’s securities Beneficially Owned by you, do you have
just “Voting Power” (the power to vote or direct the voting of such securities) or just “Investment Power” (the power to dispose or direct the disposition of such securities), rather than both Voting Power and Investment Power?

 A situation wherein the “Voting Power” and “Investment Power” are held by different persons would
arise, for example, where a voting trust is established under a trust agreement requiring the trustee to vote on all corporate matters but reserving to the grantor the power to direct the disposition of the securities. If you mark “Yes,”
please provide detailed information regarding such powers on a separate piece of paper. 
 Yes
☐                    No ☐ 
  

	8.	 With respect to any of the Corporation’s securities Beneficially Owned by you, is the
“Voting Power” or “Investment Power” not exercised exclusively by you (for example, shares held jointly with another person or shares subject to a voting trust)? 

In any such instance, you must state whether the “Voting Power” or “Investment Power” is shared by another person with you,
or exercised by another person exclusively, naming such person and describing his/her relationship to you and to the Corporation. If you mark “Yes,” please provide detailed information regarding such powers on a separate piece of paper.

 Yes ☐                    No
☐ 

  
 B-3 

	9.	 Nature of Beneficial Ownership 

 

	 	a.	 Is the Selling Stockholder a natural person? 

Yes ☐                    No ☐

  

	 	b.	 Is the Selling Stockholder required to file, or is it a wholly owned subsidiary of a company that is required
to file, periodic and other reports (for example, Form 10K, 10-Q, 8-K) with the SEC pursuant to Section 13(a) or 15(d) of the Exchange Act?

 Yes
☐                    No ☐ 
  

	 	c.	 Is the Selling Stockholder an investment company, or a subsidiary of an investment company, registered under
the Investment Company Act of 1940, as amended? 

 Yes
☐                    No ☐ 

If a subsidiary, please identify the publicly held parent entity: 
  

	 	d.	 Please describe the ultimate controlling person or manager of the Selling Stockholder (publicly traded,
privately owned, managed by another entity); and, if controlled or managed by another entity, provide the exact legal description of such entity (repeat this step until the last entity described is managed by a natural person, a reporting entity
under the Securities Exchange Act of 1934, or an investment company registered under the Investment Company Act of 1940, as amended). 

  

			
		  	  

		  	  

		  	  

  

	10.	 Please provide the names of each person or persons having voting and investment control over the
Corporation’s securities that the entity owns (e.g., director(s), general partner(s), managing member(s), etc.). 

  

			
		  	  

		  	  

		  	  

  

	C.	 CERTAIN TRANSACTIONS 

 

	1.	 If you, any of your associates, or any immediate family members had or will have any direct or indirect
material interest in any transactions or series of transactions to which the Corporation or any of its subsidiaries was a party at any time since January 1, 2019, or in any currently proposed transactions or series of transactions in which the
Corporation or any of its subsidiaries will be a party, in which the amount involved exceeds $120,000, please specify (a) the names of the parties to the transaction(s) and their relationship to you, (b) the nature of the interest in the
transaction, (c) the amount involved in the transaction, and (d) the amount of the interest in the transaction. If the answer is “none,” please so state. 

	

			
		  	  

		  	  

		  	  

		  	  

  
 B-4 

 The undersigned consents to being named a Selling Stockholder in the Registration Statement. Further, the
undersigned consents to the Corporation’s use and disclosure of the information contained herein in the Registration Statement and to the Corporation’s reliance on the information contained herein in connection therewith. The answers to
the foregoing questions are true and accurate to the best of the undersigned’s knowledge and belief after reasonable investigation. The undersigned will promptly notify the Corporation if there are any material changes to, or inaccuracies in,
the information provided subsequent to the date hereof for so long as the Corporation’s securities are Beneficially Owned by the undersigned. 
 The
undersigned, duly authorized, has caused this Questionnaire to be executed and delivered as of the date above first written. 
  

			
	[SELLING STOCKHOLDER NAME]
		
	By:	 	
                     
    

		
	Name:	 	
                     
    

		
	Title:	 	
                     
    

		
	Dated:	 	
                     
    

  
 B-5 

 Annex A 

DEFINITION OF “AFFILIATE” 
  

	1.	 The term “affiliate” of a specified person means a person that directly, or indirectly through one or
more intermediaries, controls, or is controlled by, or is under common control with, the specified person. 

 DEFINITION OF
“BENEFICIAL OWNERSHIP” 
  

	1.	 A “Beneficial Owner” of a security includes any person who, directly or indirectly, through any
contract, arrangement, understanding, relationship or otherwise has or shares: 

  

	 	(a)	 Voting power which includes the power to vote, or to direct the voting of, such security; and/or

  

	 	(b)	 Investment power which includes the power to dispose, or direct the disposition of, such
security. 

 Please note that either voting power or investment power, or both, is sufficient for you to be considered the
beneficial owner of shares. 
  

	2.	 Any person who, directly or indirectly, creates or uses a trust, proxy, power of attorney, pooling arrangement
or any other contract, arrangement or device with the purpose or effect of divesting such person of beneficial ownership of a security or preventing the vesting of such beneficial ownership as part of a plan or scheme to evade the reporting
requirements of the federal securities acts shall be deemed to be the beneficial owner of such security. 

  

	3.	 Notwithstanding the provisions of paragraph (1), a person is deemed to be the “beneficial owner” of a
security if that person has the right to acquire beneficial ownership of such security within 60 days, including but not limited to any right to acquire: (a) through the exercise of any option, warrant or right; (b) through the conversion
of a security; (c) pursuant to the power to revoke a trust, discretionary account or similar arrangement; or (d) pursuant to the automatic termination of a trust, discretionary account or similar arrangement; provided, however, any person
who acquires a security or power specified in (a), (b) or (c) above, with the purpose or effect of changing or influencing the control of the issuer, or in connection with or as a participant in any transaction having such purpose or effect,
immediately upon such acquisition shall be deemed to be the beneficial owner of the securities which may be acquired through the exercise or conversion of such security or power. 

DEFINITION OF “IMMEDIATE FAMILY MEMBER” 
  

	1.	 The term “immediate family member” means a person’s spouse, parents, children, siblings,
mothers- and fathers-in-law; sons- and daughters-in-law, brothers- and sisters-in-law and anyone (other than domestic employees) residing in such person’s home. 

  
 B-6 

 Exhibit C 

Plan of Distribution 

This prospectus supplement relates to the offer and sale, from time to time, of shares of our Common Stock by the selling stockholders. The
term “selling stockholder” includes pledgees, donees, assignees, transferees or other successors in interest selling shares of our Common Stock received after the date of this prospectus supplement from the selling stockholders as a gift,
pledge, partnership distribution or other non-sale related transfer. We are registering the resale of shares of our Common Stock to provide the selling stockholders with freely tradable securities, but the
registration of such shares does not necessarily mean that any of such shares will be offered or sold by the selling stockholders pursuant to this prospectus supplement or at all. 

The selling stockholders may, from time to time, offer the shares of our Common Stock offered in this prospectus supplement in one or more
transactions (which may involve underwritten offerings on a firm commitment or best efforts basis, cross sales or block transactions) on the NASDAQ Global Select Market, in secondary distributions pursuant to and in accordance with the rules of the
NASDAQ Global Select Market, through one or more electronic trading platforms or services, in the over-the-counter market, in negotiated transactions, directly to one or
more purchasers, including affiliates, through the writing of options on the shares (whether such options are listed on an options exchange or otherwise), short sales or a combination of such methods of sale or any other method permitted by
applicable law, at fixed prices, at market prices or varying prices prevailing at the time of sale, at prices related to such prevailing market prices or at negotiated prices, including pursuant to one or more
“10b5-1” trading plans or similar plans. The selling stockholders may also engage in short sales against the box, puts and calls, writing options, hedging transactions and other transactions in our
securities or derivatives of our securities and may sell or deliver the shares of our Common Stock registered pursuant to this prospectus supplement in connection with these trades as permitted by applicable law, including, without limitation,
delivering such shares to a lender in satisfaction of all or part of stock borrowed from such lender in connection with a short sale. The selling stockholders may pledge or grant a security interest in some or all of the shares of our Common Stock
registered pursuant to this prospectus supplement owned by them and, if they default in the performance of their secured obligations, the pledgees or secured parties may offer and sell such shares from time to time under this prospectus supplement.

 The selling stockholders might not sell any securities under this prospectus supplement. In addition, any shares of Common Stock that
qualify for sale pursuant to an exemption from the registration requirements of the Securities Act (including, for example, under Rule 144 under the Securities Act) may be sold pursuant to such exemption rather than pursuant to this prospectus
supplement. 
 The selling stockholders may effect such transactions by selling the shares of our Common Stock offered in this prospectus
supplement to or through broker-dealers or through other agents, including electronic trading platforms or similar services, and such broker-dealers or agents may receive compensation in the form of commissions, discounts or fees from the selling
stockholders and/or the purchasers of shares for whom they may act as agent. Sales effected with a broker-dealer may involve ordinary brokerage transactions, transactions in which the broker-dealer solicits purchasers or transactions in which the
broker-dealer is principal and resells for its account. The selling stockholders and any agents or broker-dealers that participate in the distribution of the shares of Common Stock offered in this prospectus supplement may be deemed to be
“underwriters” within the meaning of the Securities Act, and any commissions or discounts received by them and any profit on the sale of registered shares may be deemed to be underwriting commissions or discounts under the Securities Act.

  
 C-1 

 In the event of a “distribution” of the shares of our Common Stock offered in this
prospectus supplement, the selling stockholders, any selling broker-dealer or agent and any “affiliated purchasers” may be subject to Regulation M under the Exchange Act, which would prohibit, with certain exceptions, each such person from
bidding for or purchasing any security which is the subject of such distribution until his participation in that distribution is completed. In addition, Regulation M under the Exchange Act prohibits certain “stabilizing bids” or
“stabilizing purchases” for the purpose of pegging, fixing or stabilizing the price of Common Stock in connection with this offering. 

At a time a particular offering of shares of our Common Stock is made, an additional prospectus supplement, if required, may be distributed
that will set forth the name or names of any dealers or agents and any commissions and other terms constituting compensation from the selling stockholders and any other required information. Shares of our Common Stock may be sold from time to time
at varying prices determined at the time of sale or at negotiated prices. 

  
 C-2Document

   Exhibit 4.1                                                                                           

DESCRIPTION OF REGISTRANT’S SECURITIES REGISTERED PURSUANT TO SECTION 12 OF THE SECURITIES EXCHANGE ACT OF 1934
Description of Capital Stock
The following description summarizes the most important terms of the capital stock of Convey Health Solutions Holdings, Inc. (“we”, “us”, “our” or the “Company”). Our second amended and restated certificate of incorporation, as amended (the “amended and restated certificate of incorporation”) and third amended and restated bylaws (the “amended and restated bylaws”), each of which is filed as an exhibit to this Annual Report on Form 10-K, and certain provisions of those documents and of the Delaware General Corporation Law (the “DGCL”) are summarized below. The following descriptions of our capital stock and provisions of our amended and restated certificate of incorporation, our amended and restated bylaws and provisions of the DGCL are summaries and are qualified by reference to our amended and restated certificate of incorporation and our amended and restated bylaws as well as to the relevant provisions of the DGCL.
Authorized Capital Stock
Our authorized capital stock consists of 500,000,000 shares of common stock, par value $0.01 per share, and 25,000,000 shares of preferred stock, par value $0.01 per share. As of March 1, 2022, we had 73,194,171 shares of common stock outstanding, held of record by 37 stockholders, and no shares of preferred stock outstanding.

Common Stock
Holders of our common stock are entitled to one vote per share on all matters submitted to a vote of stockholders, including the election of directors. Our common stockholders are not entitled to cumulative voting in the election of directors. Subject to preferences that may be applicable to any outstanding shares of preferred stock, holders of our common stock are entitled to receive ratably such dividends as may be declared by our Board of Directors out of funds legally available therefor if our Board of Directors, in its discretion, determines to issue dividends and only then at the times and in the amounts that our Board of Directors may determine. Upon our liquidation, dissolution or winding up, holders of our common stock are entitled to receive their ratable share of our net assets available after payment of all debts and other liabilities, subject to the prior preferential rights and payment of liquidation preferences, if any, of any outstanding shares of preferred stock. Holders of our common stock have no preemptive, subscription, conversion or redemption rights. There are no redemption or sinking fund provisions applicable to our common stock. The rights, preferences and privileges of holders of our common stock are subject to, and may be adversely affected by, the rights of the holders of shares of any series of preferred stock that we may designate in the future.
Preferred Stock
Our Board of Directors has the authority, subject to the limitations imposed by Delaware law and the listing rules of the New York Stock Exchange (“NYSE”), without any further vote or action by our stockholders, to issue preferred stock in one or more series and to fix the designations, powers, preferences, limitations and rights of the shares of each series, including:
•dividend rates;

•conversion rights;

•voting rights;

•terms of redemption and liquidation preferences; and

•the number of shares constituting each series.
Satisfaction of any dividend preferences of outstanding shares of preferred stock would reduce the amount of funds available for the payment of dividends on shares of our common stock. Holders of shares of preferred stock may be entitled to receive a preference payment in the event of our liquidation, dissolution or winding-up before any payment is made to the holders of shares of our common stock.

Our Board of Directors may authorize the issuance of preferred stock with voting or conversion rights that could adversely affect the voting power or other rights of the holders of our common stock. The issuance of preferred stock, while providing flexibility in connection with possible acquisitions and other corporate purposes, could, among other things, have the effect of delaying, deferring or preventing a change in control of the Company and may adversely affect the market price of our common stock and the voting and other rights of the holders of our common stock.
Registration Rights
In connection with our initial public offering, we entered into a Registration Rights Agreement with TPG Cannes Aggregation, L.P. (collectively with its permitted transferees that are affiliates, “our principal stockholder”), the Chairman of our Board of Directors and our Chief Executive Officer (the “Registration Rights Agreement”). The Registration Rights Agreement provides the stockholders party thereto with certain registration rights as described below:
Demand Registration Rights
Our principal stockholder has the right to demand that we file registration statements. These registration rights are subject to specified conditions and limitations, including the right of the underwriters, if any, to limit the number of shares included in any such registration under specified circumstances. Upon such a request, we will be required to use commercially reasonable efforts to promptly effect the registration.
Piggyback Registration Rights
If we propose to register any shares of our equity securities under the Securities Act of 1933, as amended (the “Securities Act”) either for our own account or for the account of any other person, then the parties to the Registration Rights Agreement will be entitled to notice of the registration and will be entitled to include their shares of common stock in the registration statement. These piggyback registration rights are subject to specified conditions and limitations, including the right of the underwriters, if any, to limit the number of shares included in any such registration under specified circumstances.
Shelf Registration Rights
At any time after we become eligible to file a registration statement on Form S-3, our principal stockholder will be entitled to have its shares of common stock registered by us on a Form S-3 registration statement at our expense. These shelf registration rights are subject to specified conditions and limitations.
Expenses and Indemnification
We will pay all expenses relating to any demand, piggyback or shelf registration, other than underwriting discounts and commissions and any transfer taxes, subject to specified conditions and limitations. The Registration Rights Agreement includes customary indemnification provisions, including indemnification of the participating holders of shares of common stock and their directors, officers and employees by us for any losses, claims, damages or liabilities in respect thereof and expenses to which such holders may become subject under the Securities Act, state law or otherwise.
Certain Anti-Takeover Provisions of our Amended and Restated Certificate of Incorporation, our Amended and Restated Bylaws and Delaware Law
Certain provisions of our amended and restated certificate of incorporation, our amended and restated bylaws and the DGCL may discourage or make more difficult a takeover attempt that a stockholder might consider to be in his, her or its best interest. These provisions may also adversely affect the prevailing market price for shares of our common stock. We believe that the benefits of increased protection give us the potential ability to negotiate with the proponent of an unsolicited proposal to acquire or restructure us, which may result in an improvement of the terms of any such proposal in favor of our stockholders, and outweigh any potential disadvantage of discouraging those proposals.
Authorized but Unissued Shares of Capital Stock
Our authorized but unissued shares of common stock and preferred stock are available for future issuance without stockholder approval, subject to the applicable provisions of the DGCL and rules of the NYSE. These additional shares may be used for a variety of corporate purposes, including future public offerings to raise additional capital, corporate acquisitions and employee benefit plans.

One of the effects of the existence of authorized but unissued common stock or preferred stock may be to enable our Board of Directors to issue shares to persons friendly to current management, which issuance could render more difficult or discourage an attempt to obtain control of the Company by means of a merger, tender offer, proxy contest or otherwise, and thereby protect the continuity of our management and possibly deprive our stockholders of opportunities to sell their shares of common stock at a price higher than the prevailing market price.

Classified Board of Directors
Our amended and restated certificate of incorporation provides that our Board of Directors will be divided into three classes of directors, with the classes to be as nearly equal in number as possible, and with the directors serving three-year staggered terms. Accordingly, approximately one-third of our Board of Directors will be elected each year. These provisions may have the effect of deferring, delaying or discouraging hostile takeovers, or changes in control of us or our management.
Vacancies
Our amended and restated certificate of incorporation provides that any vacancies on our Board of Directors will be filled only by the affirmative vote of a majority of the remaining directors, even if less than a quorum, or by a sole remaining director or by the stockholders; provided, however, that after the first time when our principal stockholder ceases to beneficially own, in the aggregate, at least a majority of the voting power of our outstanding common stock, any newly created directorship on our Board of Directors that results from an increase in the number of directors and any vacancy occurring in our Board of Directors may only be filled by a majority of the directors then in office, although less than a quorum, or by a sole remaining director (and not by the stockholders). As of December 31, 2021, our principal stockholder holds approximately 74.7% of our common stock.
Additionally, a Stockholders Agreement by and between us and TPG Cannes Aggregation, L.P. provides that our principal stockholder may fill any vacancy occurring in our Board of Directors if such vacancy was caused by the departure of our principal stockholder’s director designees. 
Special Meetings of Stockholders
Our amended and restated certificate of incorporation and amended and restated bylaws provide that special meetings of our stockholders may be called at any time only by or at the direction of our Board of Directors or the Chairperson of our Board of Directors; provided, however, at any time when our principal stockholder beneficially owns, in the aggregate, at least a majority of the voting power of our outstanding shares of common stock, special meetings of our stockholders may be called by the Chairperson of our Board of Directors or our Board of Directors at the written request of our principal stockholder. Our amended and restated bylaws prohibit the conduct of any business at a special meeting other than as specified in the notice for such meeting.
Stockholder Action by Written Consent
Our amended and restated certificate of incorporation precludes stockholder action by written consent once our principal stockholder ceases to beneficially own, in the aggregate, at least a majority of the voting power of our outstanding shares of common stock.
Advance Notice Requirements for Stockholder Proposals and Director Nominations
Our amended and restated bylaws establish advance notice procedures with respect to stockholder proposals and the nomination of candidates for election as directors, other than nominations made by or at the direction of our Board of Directors or a committee of our Board of Directors. In order for any matter to be “properly brought” before a meeting, a stockholder will have to comply with advance notice requirements and provide us with certain information. Generally, to be timely, a stockholder’s notice must be received at our principal executive offices not less than 90 days nor more than 120 days prior to the first anniversary date of the immediately preceding annual meeting of stockholders. Our amended and restated bylaws also specify requirements as to the form and content of a stockholder’s notice. Our amended and restated bylaws allow the chairperson of the meeting at a meeting of the stockholders to adopt rules and regulations for the conduct of meetings which may have the effect of precluding the conduct of certain business at a meeting if the rules and regulations are not followed. These provisions will not apply to our principal stockholder until the first time when it ceases to beneficially own, in the aggregate, at least a majority of our outstanding common stock. These provisions may also defer, delay or discourage a potential acquirer from conducting a solicitation of proxies to elect the acquirer’s own slate of directors or otherwise attempting to influence or obtain control of us.

Amendment of Amended and Restated Certificate of Incorporation and Amended and Restated Bylaws
Our amended and restated certificate of incorporation and amended and restated bylaws provide that our Board of Directors is expressly authorized to amend, alter, repeal or replace, in whole or in part, our amended and restated bylaws without a stockholder vote in any manner not inconsistent with the laws of the State of Delaware or our amended and restated certificate of incorporation. For as long as our principal stockholder beneficially owns, in the aggregate, at least a majority in voting power of our stock entitled to vote generally in the election of directors, any amendment, alteration, rescission or replacement of our amended and restated bylaws by our stockholders will require the affirmative vote of a majority in voting power of the outstanding shares of our stock present in person or represented by proxy at the meeting and entitled to vote on such amendment, alteration, rescission or replacement. At any time when our principal stockholder beneficially owns, in the aggregate, less than a majority in voting power of our stock entitled to vote generally in the election of directors, any amendment, alteration, rescission or replacement of specified provisions of our amended and restated bylaws by our stockholders will require the affirmative vote of the holders of at least 66 2/3% in voting power of all the then outstanding shares of stock entitled to vote thereon, voting together as a single class.
The DGCL provides generally that the affirmative vote of a majority of the outstanding shares entitled to vote thereon, voting together as a single class, is required to amend a corporation’s certificate of incorporation or bylaws, unless the corporation’s certificate of incorporation requires a greater percentage. Our amended and restated certificate of incorporation provides that at any time when our principal stockholder beneficially owns, in the aggregate, less than a majority in voting power of our stock entitled to vote generally in the election of directors, certain specified provisions in our amended and restated certificate of incorporation may be amended, altered, rescinded or replaced only by the affirmative vote of the holders of at least 66 2/3% in voting power of all the then outstanding shares of our stock entitled to vote thereon, voting together as a single class, including the following provisions:
•the provisions providing for a classified board of directors (the election and term of our directors);
•the provisions regarding resignation and removal of directors;
•the provisions regarding entering into business combinations with interested stockholders;
•the provisions regarding stockholder action by written consent;
•the provisions regarding calling special meetings of stockholders;
•the provisions regarding filling vacancies on our Board of Directors and newly created directorships;
•the provision establishing the Court of Chancery of the State of Delaware as the exclusive forum for certain litigation;
•the provisions eliminating monetary damages for breaches of fiduciary duty by a director;
•the provision requiring a 66 2/3% supermajority vote for stockholders to amend our bylaws; and
•the amendment provision requiring that the above provisions be amended only with a 662∕3% supermajority vote.
Section 203 of the Delaware General Corporation Law
Our amended and restated certificate of incorporation contains a provision opting out of Section 203 of the DGCL. In general, Section 203 prohibits a publicly held Delaware corporation from engaging in a “business combination” with an “interested stockholder” for three years following the date that such stockholder became an interested stockholder, unless the business combination is approved in a prescribed manner. A “business combination” includes, among other things, a merger, an asset or stock sale or other transaction resulting in a financial benefit to the interested stockholder. An “interested stockholder” is a person who, together with its affiliates and associates, owns, or did own within three years prior to the determination of interested stockholder status, 15% or more of the corporation’s voting stock.
However, our amended and restated certificate of incorporation contains similar provisions to Section 203 of the DGCL providing that we may not engage in a “business combination” with any “interested stockholder” for three years following the date that such stockholder became an interested stockholder, unless the business combination is approved in a prescribed manner. Our amended and restated certificate of incorporation provides that our principal stockholder and its affiliates and any of their respective direct or indirect transferees and any group as to which such persons are a party do not constitute “interested stockholders” for purposes of this provision.

Certain Provisions of Our Amended and Restated Certificate of Incorporation and Delaware Law
Dissenters’ Rights of Appraisal and Payment

Under the DGCL, with certain exceptions, our stockholders will have appraisal rights in connection with a merger or consolidation in which we are a constituent entity. Pursuant to the DGCL, stockholders who properly demand and perfect appraisal rights in connection with such merger or consolidation will have the right to receive payment of the fair value of their shares as determined by the Delaware Court of Chancery, if any, on the amount determined to be the fair value, from the effective time of the merger or consolidation through the date of payment of the judgment.
Stockholders’ Derivative Actions
Under the DGCL, any of our stockholders may bring an action in our name to procure a judgment in our favor, also known as a derivative action, provided that the stockholder bringing the action is a holder of our shares at the time of the transaction to which the action relates or such stockholder’s stock thereafter devolved by operation of law. To bring such an action, the stockholder must otherwise comply with Delaware law regarding derivative actions.
Exclusive Forum
Our amended and restated certificate of incorporation requires, to the fullest extent permitted by law, that (1) any derivative action or proceeding brought on behalf of the Company, (2) any action asserting a claim of breach of a fiduciary duty owed by any director, officer, employee or stockholder of the Company to the Company or the Company’s stockholders, (3) any action asserting a claim arising pursuant to any provision of our amended and restated certificate of incorporation, our amended and restated bylaws or the DGCL or as to which the DGCL confers jurisdiction on the Court of Chancery of the State of Delaware or (4) any action asserting a claim governed by the internal affairs doctrine, in each case, may be brought only in specified courts in the State of Delaware. As described below, this provision will not apply to suits brought to enforce any duty or liability created by the Securities Act or the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or rules and regulations thereunder.
Our amended and restated certificate of incorporation also provides that the federal district courts of the United States of America will be the exclusive forum for the resolution of any complaint asserting a cause of action against us or any of our directors, officers, employees or agents and arising under the Securities Act. However, Section 22 of the Securities Act provides that federal and state courts have concurrent jurisdiction over lawsuits brought pursuant to the Securities Act or the rules and regulations thereunder. To the extent the exclusive forum provision restricts the courts in which claims arising under the Securities Act may be brought, there is uncertainty as to whether a court would enforce such a provision. Our amended and restated certificate of incorporation provides that any person or entity purchasing or otherwise acquiring any interest in shares of our capital stock will be deemed to have notice of and to have consented to the foregoing provision; provided, however, that investors cannot waive compliance with the federal securities laws and the rules and regulations thereunder. This provision does not apply to claims brought under the Exchange Act.
We recognize that the forum selection clause in our amended and restated certificate of incorporation may impose additional litigation costs on stockholders in pursuing any such claims, particularly if the stockholders do not reside in or near the State of Delaware. Additionally, the forum selection clause in our amended and restated certificate of incorporation may limit our stockholders’ ability to bring a claim in a forum that they find favorable for disputes with us or our directors, officers, employees or agents, which may discourage such lawsuits against us and our directors, officers, employees and agents even though an action, if successful, might benefit our stockholders. The Court of Chancery of the State of Delaware may also reach different judgments or results than would other courts, including courts where a stockholder considering an action may be located or would otherwise choose to bring the action, and such judgments may be more or less favorable to us than our stockholders.
Corporate Opportunities
The DGCL permits corporations to adopt provisions renouncing any interest or expectancy in certain opportunities that are presented to the corporation or its officers, directors or stockholders. Our amended and restated certificate of incorporation, to the maximum extent permitted from time to time by Delaware law, renounces any interest or expectancy that we have in, or right to be offered an opportunity to participate in, specified business opportunities that are from time to time presented to our officers, directors or stockholders or their respective affiliates, other than those officers, directors, stockholders or affiliates who are our or our subsidiaries’ employees. Our amended and restated certificate of incorporation provides that, to the fullest extent permitted by law, our principal stockholder or any of 

its affiliates or any director who is not employed by us or his or her affiliates will have no duty to refrain from (1) engaging in the same, similar or competing business activities or lines of business as us or our affiliates or (2) doing business with any of our or our affiliates’ clients or customers, or making investments in competing businesses of us or our affiliates. In addition, to the fullest extent permitted by law, in the event that our principal stockholder or any non-employee director acquires knowledge of a potential transaction or other business opportunity which may be a corporate opportunity for itself or himself or herself, or their or his or her affiliates or for us or our affiliates, such person will have no duty to communicate or offer such transaction or business opportunity to us or any of our affiliates and they may take any such opportunity for themselves or offer it to another person or entity. Our amended and restated certificate of incorporation does not renounce our interest in any business opportunity that is expressly offered to a non-employee director solely in his or her capacity as a director or officer of the Company. To the fullest extent permitted by law, no business opportunity will be deemed to be a potential corporate opportunity for us unless we would be permitted to undertake the opportunity under our amended and restated certificate of incorporation, we have sufficient financial resources to undertake the opportunity and the opportunity would be in line with our business. Our amended and restated certificate of incorporation provides that, at any time when our principal stockholder beneficially owns, in the aggregate, less than a majority in voting power of our stock entitled to vote generally in the election of directors, any alteration or amendment to, or repeal of, or the adoption of any provision inconsistent with, the provisions described in this “Corporate Opportunities” section will require the affirmative vote of the holders of at least 80% in voting power of all the then outstanding shares of our stock entitled to vote thereon, voting together as a single class.
Limitation of Liability and Indemnification of Directors and Officers
Our amended and restated certificate of incorporation includes provisions that limit the personal liability of our directors for monetary damages for breach of their fiduciary duties as directors, except to the extent that such limitation is not permitted under the DGCL. Such limitation shall not apply, except to the extent permitted by the DGCL, to (1) any breach of a director’s duty of loyalty to us or our stockholders, (2) acts or omissions not in good faith or that involve intentional misconduct or a knowing violation of law, (3) any unlawful payment of a dividend or unlawful stock repurchase or redemption, as provided in Section 174 of the DGCL, or (4) any transaction from which a director derived an improper personal benefit. These provisions will have no effect on the availability of equitable remedies such as an injunction or rescission based on a director’s breach of his or her duty of care.
Our amended and restated certificate of incorporation and our amended and restated bylaws provide for indemnification, to the fullest extent permitted by the DGCL, of any person made or threatened to be made a party to any action, suit or proceeding by reason of the fact that such person is or was a director, officer, employee or agent of the Company, or, at the request of the Company, serves or served as a director, officer, employee or agent of another corporation, partnership, joint venture, trust or any other enterprise, against all expenses, judgments, fines, amounts paid in settlement and other losses actually and reasonably incurred in connection with the defense or settlement of such action, suit or proceeding. In addition, we have entered into indemnification agreements with each of our directors and executive officers pursuant to which we agreed to indemnify each such director and executive officer to the fullest extent permitted by the DGCL. Insofar as indemnification for liabilities arising under the Securities Act may be permitted to directors and executive officers, we have been informed that in the opinion of the Securities and Exchange Commission such indemnification is against public policy and is therefore unenforceable.
Listing
Our common stock is listed on the NYSE under the symbol “CNVY”.
Transfer Agent and Registrar
The transfer agent and registrar for our common stock is American Stock Transfer & Trust Company, LLC. The transfer agent’s address is 6201 15th Avenue, Brooklyn, New York 11219.

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00342-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00342-of-00352.parquet"}]]